EDGAR Filing Documents for 0001144204-17-031150

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001144204-17-031150

Filing Date

2017-06-06

Accepted

2017-06-06 06:06:27

Documents

Period of Report

2017-06-05

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 6-K	v468457_6k.htm	6-K	10260
2	EXHIBIT 99.1	v468457_ex99-1.htm	EX-99.1	16938
3	GRAPHIC	orpn_logo.jpg	GRAPHIC	2932
	Complete submission text file	0001144204-17-031150.txt		32515

Mailing Address 37 DEREH MENACHEM BEGIN ST. 15TH FLOOR TEL AVIV L3 6522042

Business Address 37 DEREH MENACHEM BEGIN ST. 15TH FLOOR TEL AVIV L3 6522042 972 (0) 3 7326616

Bioblast Pharma Ltd. (Filer) CIK: 0001596812 (see all company filings)